PSPietro Schinocca

Pietro Schinocca

*This is an algorithmically generated author record based on publicly available information.

Pietro Schinocca has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Carrier screening for spinal muscular atrophy in Italian population.

    by Francesco Calì, Giuseppa Ruggeri, Valeria Chiavetta, Carmela Scuderi, Sebastiano Bianca, Chiara Barone, Alda Ragalmuto, Pietro Schinocca, Girolamo Aurelio Vitello, Valentino Romano, et al.


  • Comparative multiplex dosage analysis in spinocerebellar ataxia type 2 patients

    by F. Calì, V. Chiavetta, A. Ragalmuto, M. Vinci, G. Ruggeri, P. Schinocca, V. Romano

    We developed a new application of comparative multiplex dosage analysis (CMDA) for evaluation of the ataxin 2 gene. Expansions of the triplet CAG can cause spinocerebellar ataxia type 2 (SCA2), a neurodegenerative disease with an autosomal-dominant mode of inheritance. Molecular diagnosis of SCA2 is routinely based on the use of conventional PCR to detect the CAG expansion. However, PCR does not amplify an allele with an expansion of many triplets (>80), which is typically found in infantile and juvenile forms of SCA2, thus leading to false negatives. We propose the analysis of the ATXN2 gene by CMDA to complement existing methods currently used for the detection of large expansions of the CAG repeat. Using CMDA, the presence of any longer mutated allele in a heterozygous patient or fetus would be inferred due to dosage variation of the very frequent normal allele #22. CMDA can be completed in 1 day, at very low cost, and would be a useful tool for prenatal diagnosis and for diagnosis of presymptomatic forms of early-onset SCA2

  • Multiplex ligation-dependent probe amplification detection of an unknown large deletion of the CREB-binding protein gene in a patient with Rubinstein-Taybi Syndrome

    by F. Calì, P. Failla, V. Chiavetta, A. Ragalmuto, G. Ruggeri, P. Schinocca, C. Schepis, V. Romano, C. Romano

    Rubinstein-Taybi syndrome is a rare autosomal dominant congenital disorder characterized by postnatal growth retardation, psychomotor developmental delay, skeletal anomalies, peculiar facial morphology, and tumorigenesis. Mutations in the gene encoding the cAMP response element-binding protein (CREB, also known as CREBBP or CBP) on chromosome 16p13.3 have been identified. In addition, some patients with low intelligence quotients and autistic features bear large deletions. Based on these observations, we used multiplex ligation-dependent probe amplification to search for large deletions affecting the CREBBP gene in a Rubinstein-Taybi syndrome patient. We identified a novel heterozygote deletion removing five exons (exons 17-21), encoding the histone acetyltransferase domain. We propose the use of multiplex ligation-dependent probe amplification as a fast, accurate and cheap test for detecting large deletions in the CREBBP gene in the sub-group of Rubinstein-Taybi syndrome patients with low intelligence quotients and autistic features.


  • Open Access

    Exon deletions of the phenylalanine hydroxylase gene in Italian hyperphenylalaninemics

    by Francesco Calì, Giuseppa Ruggeri, Mirella Vinci, Concetta Meli, Carla Carducci, Vincenzo Leuzzi, Simone Pozzessere, Pietro Schinocca, Alda Ragalmuto, Valeria Chiavetta, et al.

    Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.


  • Novel deletion of the E3A ubiquitin protein ligase gene detected by multiplex ligation-dependent probe amplification in a patient with Angelman syndrome

    by Francesco Calì, Alda Ragalmuto, Valeria Chiavetta, Giuseppe Calabrese, Marco Fichera, Mirella Vinci, Giuseppa Ruggeri, Pietro Schinocca, Maurizio Sturnio, Salvatore Romano, et al.

    Angelman syndrome (AS) is a severe neurobehavioural disorder caused by failure of expression of the maternal copy of the imprinted domain located on 15q11-q13. There are different mechanisms leading to AS: maternal microdeletion, uniparental disomy, defects in a putative imprinting centre, mutations of the E3 ubiquitin protein ligase (UBE3A) gene. However, some of suspected cases of AS are still scored negativeud to all the latter mutations. Recently, it has been shown that a proportion of negative cases bear large deletions overlapping one or more exons of the UBE3A gene. These deletions are difficult to detect by conventional gene-scanning methods due to the masking effect by the non-deleted allele. In this study, we have used forud the first time multiplex ligation-dependent probe amplification (MLPA) and comparative multiplex dosage analysis (CMDA) to search for large deletions affecting the UBE3A gene. Using this approach, we identified aud novel causative deletion involving exon 8 in an affected sibling. Based on our results, we propose the use of MLPA as a fast, accurate and inexpensive test to detectud large deletions in the UBE3A gene in a small but significant percentage of AS patients


  • 1.5 Mb de novo 22q11.21 microduplication in a patient with cognitive deficits and dysmorphic facial features

    by A Alberti, C Romano, M Falco, F Calì, P Schinocca, O Galesi, A Spalletta, D Di Benedetto, M Fichera

    The 22q11.2 microduplication syndrome is caused by non‐allelic homologous recombination mediated by misalignments of low copy repeats located in the region deleted in the DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS). The variable phenotype of such condition, consisting in a combination of dysmorphic facial features, cognitive deficits, velopharyngeal insufficiency, congenital heart defects and immunologic derangement, is caused usually in 90% of cases by a 3 Mb deletion or in a minority of cases (7%) by a 1.5 Mb deletion. The most common reciprocal event of deletion is the 3 Mb duplication, reported more recently with a variable phenotype, ranging from multiple defects to normality. In this study, we report a 2.5‐year‐old girl with cognitive deficits and dysmorphic facial features such as superior placement of eyebrows, upslanting palpebral fissures, widely spaced eyes, broad nasal bridge and epicanthal folds. Fluorescent in situ hybridization for DGS/VCFS region on metaphase chromosomes did not show any apparent anomaly. Subsequent array comparative genomic hybridization study, confirmed by multiplex ligation‐dependent probe assay and microsatellite analysis, disclosed a 1.5 Mb de novo 22q11.21 duplication concerning the same chromosomal region deleted in a minority of patients with DGS. These findings identify the minimal duplicated region leading to this emerging syndrome.


  • Suggestive evidence for association of D2S2188 marker (2q31.1) with autism in 143 Sicilian (Italian) TRIO families

    by Valentino Romano, Francesco Calì, Gregorio Seidita, Mario Mirisola, Rosalba P. D'Anna, Giovanna Gambino, Pietro Schinocca, Salvatore Romano, Giovanni F. Ayala, Fabio Canziani, et al.

    We have screened 143 Sicilian (Italian) families with one autistic child to verify, by a linkage disequilibrium approach, the involvement of the 2q31.1 region in the cause of the disease in these families. Our study design includes the use of intrafamilial association to prevent a population stratification bias and ethnic homogeneity of the sample. The results of our analysis provided suggestive evidence of the occurrence of transmission disequilibrium between autism and the D2S2188 polymorphism in Sicilian TRIO families, a finding which provides further and independent support to the hypothesis of the existence of a susceptibility gene (or genes) for autism on chromosome 2q.


  • PAH Gene Mutations in the Sicilian Population: Association with Minihaplotypes and Expression Analysis

    by Mario G. Mirisola, Francesco Cali, Angelo Gloria, Pietro Schinocca, Monica D'Amato, Georgia Cassara, Giacomo De Leo, Letizia Palillo, Concetta Meli, Valentino Romano